Cited by 705Bone Metabolism and DiseasesBone health and osteoporosis researchEstrogen and related hormone effects

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Open access

Cenci, Simone, Weitzmann, M. Neale, Roggia, Cristiana, Namba, Noriyuki, Novack, Deborah, Woodring, Jessica, Pacifici, Roberto·2000·Journal of Clinical Investigation

DOI 10.1172/jci11066PMC PMC381439

Open this paper in CoChat — free account Open PDF

Abstract

Physiologic osteoclast renewal results from the differentiation of bone marrow monocytes (BMMs) into osteoclasts, a process induced by the simultaneous stimulation of osteoclast precursors by macrophage colonystimulating factor (M-CSF) and a TNF-related factor known as receptor activator of NF-κB ligand (RANKL; also known as OPGL, TRANCE, or ODF) (1-3).Although upregulation of osteoclast formation is recognized as the main mechanism by which estrogen deficiency induces bone loss (4, 5), the responsible cells and cytokines are not completely understood.Bone marrow stromal cells are essential for physiologic osteoclast renewal because they represent a major source of RANKL and M-CSF and provide a physical support for nascent osteoclasts (6).However, in stimulated conditions additional bone marrow cells contribute to regulate osteoclast formation by producing soluble and membrane-bound pro-and antiosteoclastogenic cytokines.Among them are activated T cells, which stimulate osteoclast formation through increased production of RANKL, a phenomenon that contributes to inflammation-induced bone loss (7).T cells express estrogen receptors, and estrogen directly regulates T-cell function and cytokine production (8-11).Moreover, T-cell subset alterations occur in women with postmenopausal osteoporosis (12, 13).Taken together, these findings suggest that T cells may contribute to enhanced osteoclast formation and induce bone loss not only during inflammation, but also in conditions of estrogen deficiency.In this study we have investigated the role of T cells in ovariectomy-induced bone loss.We report that ovariectomy-enhanced T-cell production of TNF-α, which, acting through the TNF-α receptor p55, augments M-CSF-and RANKL-induced osteoclastogenesis.We also show that ovariectomy failed to induce bone loss, stimulate bone resorption, and increase osteoclast formation in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. Methods Experimental protocol.All animal procedures were approved by the Animal Care and Use Committee of Barnes-Jewish Hospital.Wild-type C57BL/6 mice, C57BL/6 homozygous (nu/nu) athymic nude mice (14), and heterozygous (nu/+) euthymic control littermates were obtained from Taconic Farms Inc. (Germantown, New York, USA).C57BL/6 mice lacking either TNF-α receptor 1 (p55 -/-) or TNF-α receptor II (p75 -/-) and wild-type controls of the same genetic background were obtained from Jackson Laboratories (Bar Harbor, Maine, USA).At 5 weeks of age mice were either sham operated or ovariectomized (OVX), and either left untreated or treated with 17β estradiol (0.16 µg/d) for 4 weeks as described (15,16).In vitro osteoclast generation, cytokine neutralization, and TNF-α assay.Bone marrow cells were either cultured unfractionated or depleted of stromal cells by adherence for 12 hours.The nonadherent fraction was used as a source of T cells and BMM precursors and was found to

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci11066

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,345
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,309
Bone histomorphometry : techniques and interpretation
Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,160

Flagged first, then by citations

Show all 57 references

Research works printed but not linked: 2

Olsen, 1996, Endocr Rev, 17, 369
Fujita, 1984, Miner Electrolyte Metab, 10, 375

Sorted by citations

Items 501–600 of 703

Cortical bone water changes in ovariectomized rats during the early postoperative period: Objective evaluation using sweep imaging with Fourier transform
Sukenari, T., Horii, M., Ikoma, K., Kido, M., Hayashi, S., Hara, Y., Yamasaki, T., Matsuda, K., Kawata, M., & Kubo, T. (2014) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24765 · Cited by 8
An impulsive mathematical model of bone formation and resorption: effects of parathyroid hormone, calcitonin and impulsive estrogen supplement
Chaiya, I., & Rattanakul, C. (2017) · Advances in Difference Equations · doi:10.1186/s13662-017-1206-2 · Cited by 7
Sex Hormones, Pregnancy, and Immune Function
Papenfuss, T. L., & Whitacre, C. C. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00010-3 · Cited by 7
Immune System and Postmenopausal Bone Loss
D’Amelio, P., & Isaia, G. C. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9061-7 · Cited by 7
Do γδ T cells predict osteonecrosis of the jaw?
Weitzmann, M. N. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1886 · Cited by 7
Self-citation
Osteoclast Formation from Peripheral Blood of Patients with Bone-lytic Diseases
de Vries, T. J., & Everts, V. E. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9057-3 · Cited by 7
The Impact of Menopause on Immune Senescence
Engelmann, F. (2012) · Open Longevity Science · doi:10.2174/1876326x01206010101 · Cited by 7
Inflammatory Cytokines
Nanes, M. S., & Pacifici, R. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_5 · Cited by 7
Self-citation
Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation
Carlos, A. C. A. M., Coelho, L. M. C., Malta, C. E. N., Magalhães, I. A., Borges, M. M. F., da Silva, J. E., Silva, L. F. G., & Silva, P. D. B. (2023) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2023.24.8.2681 · Cited by 6
Relationships among osteoporosis, redox homeostasis, and alcohol addiction: Importance of the brain-bone axis
Martiniaková, M., Kováčová, V., Bíro, R., Mondočková, V., Šarocká, A., Pénzes, N., Folwarczna, J., & Omelka, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118063 · Cited by 9
Protecting bone in long-term HIV positive patients receiving antiretrovirals
McGinty, T., & Mallon, P. W. G. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1184570 · Cited by 6
Glucocorticoid Regulation of Body Composition and Metabolism
Opata, A. A., Cheesman, K. C., & Geer, E. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-45950-9_1 · Cited by 6
Skeletal impact of 17β-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation
Cheng, J. N., Frye, J. B., Whitman, S. A., & Funk, J. L. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-10012-3 · Cited by 6
Osteoclasts-Key Players in Skeletal Health and Disease
Novack, D. V., & Mbalaviele, G. (2017) · ASM Press eBooks · doi:10.1128/9781555819194.ch13 · Cited by 7
Self-citation
Identification of 12 hub genes associated to the pathogenesis of osteoporosis based on microarray and single-cell RNA sequencing data
Zhou, Z., Huang, Z., Khan, H. M., Liu, Y., Zhao, Z., & Kong, Q. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01116-x · Cited by 6
Effects of Bu-Shen-Ning-Xin Decoction on immune cells of the spleen and bone marrow in ovariectomized mice
Qiu, X., Gui, Y., Zhang, N., Xu, Y., Li, D., & Wang, L. (2016) · BioScience Trends · doi:10.5582/bst.2016.01012 · Cited by 6
Arthritis and Osteoporosis
(2010) · Human Kinetics eBooks · doi:10.5040/9781492595700.ch-0011 · Cited by 6
The correlation between primary ovarian insufficiency, sex hormones and immune cells: a two-step Mendelian randomization study
Hong, T., Pu, D., & Wu, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1456273 · Cited by 7
FKBP5 promotes osteogenic differentiation of mesenchymal stem cells through type-I interferon pathway Inhibition
Tang, J., Li, M., Chen, Y., Liang, Y., Yan, W., Ning, Q. X., Deng, H., Liu, H., Li, Y., & Huang, L. C. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05754-1 · Cited by 5
CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis
Ma, F., Zhou, R., Rosin, M., Zhou, I., Ownsworth, S., Memar, R. O., Wong, V. B., & Rosin, J. M. (2026) · Development · doi:10.1242/dev.205423 · Cited by 5
Estrogen deficiency induces changes in bone matrix bound water that do not closely correspond with bone turnover
Metzger, C. E., Olayooye, P., Tak, L. Y., Culpepper, O., LaPlant, A. N., Jalaie, P. K., Andoh, P.-M., Bandara, W. R., Reul, O. N., Tomaschke, A. A., et al. (2024) · Bone · doi:10.1016/j.bone.2024.117173 · Cited by 6
Advances on T cell immunity in bone remodeling and bone regeneration
Hu, W., Jinxia, D. E. N. G., Zhanpeng, S. U., Haixing, W. A. N. G., & Lin, S. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2023-0619 · Cited by 5
Menopause in Cystic Fibrosis: Special Considerations for Bone Health, Menopausal Symptoms, and Treatment
Haroon, S., Cobb, C., Sufian, S., Jain, R., Maalouf, N. M., & Putman, M. S. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.011 · Cited by 5
Investigation of Intravenous Zoledronic Acid Therapy on Circulating Lymphocyte Subpopulation in Patients with Primary Osteoporosis: A Pilot Study
Cui, M., Zhang, N., Zhang, G., Han, L., & Yu, L. Z. (2021) · Current Therapeutic Research · doi:10.1016/j.curtheres.2021.100634 · Cited by 5
Solid Tumours Show Osteotropism: Mechanisms of Bone Metastases
Roato, I., & Ferracini, R. (2013) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-013-9144-3 · Cited by 5
Manipulation of Macrophages to Enhance Bone Repair and Regeneration
Nassiri, S., Graney, P. L., & Spiller, K. L. (2014) · Mechanical engineering series · doi:10.1007/978-3-319-13266-2_5 · Cited by 5
The use of traditional treatment modalities with special mention of Piper sarmentosum in treatment of bone fracture
Estai, M. (2011) · Journal of Medicinal Plants Research · doi:10.5897/jmprx11.006 · Cited by 5
Nouveaux acteurs du remodelage osseux, rôle du système immunitaire
Thomas, T. (2010) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)32179-x · Cited by 5
Flesh-eatingStreptococcus pyogenestriggers the expression of receptor activator of nuclear factor-κB ligand
Matsui, H., Nakatani, Y., Yoshida, H., Takizawa, A., Takeuchi, O., Øverby, A., Takahashi, T., Murayama, S. Y., & Matsuo, K. (2016) · Cellular Microbiology · doi:10.1111/cmi.12581 · Cited by 5
An Evidence-Based Review of Micro-CT Assessments of the Postmenopausal Osteoporosis Rat Model
Effendy, N. M., Ibrahim, N. ‘., Mohamed, N., & Shuid, A. N. (2015) · International Journal of Pharmacology · doi:10.3923/ijp.2015.177.200 · Cited by 5
Association between pan-immune-inflammation value and bone turnover markers in Chinese patients with osteoporotic fractures: a retrospective cross-sectional study
Wang, J., Zhu, M., Li, C., Wang, G., Lü, K., & Hao, Y.-M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1660376 · Cited by 4
CD8a + GZMK + T Cells Inhibit Osteoclastogenesis in Postmenopausal Osteoporosis via the p38-MAPK Pathway
He, X., Wang, J., Liu, M., Jiang, Z., & Yuan, H. (2025) · Calcified Tissue International · doi:10.1007/s00223-025-01402-9 · Cited by 4
Osteoimmunology: the little niche with the big impact
Yadav, S., Yadav, J., Jones, D., & Humphrey, M. B. (2025) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2025.09.014 · Cited by 4
Corosolic acid modulates RANKL-triggered signaling to suppress osteoclastogenesis and ovariectomy-induced bone loss
Zhao, C., Wu, F., Zhao, L., Zhong, J., Huang, C., Jiang, Z., Zheng, J., Yang, S., Zhang, C., & Zhang, L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.10.284 · Cited by 4
Isoliquiritigenin restores bone homeostasis in osteoporotic rats by enhancing BMSCs osteogenesis via ERK1/2-mTOR-HIF-1α-glycolytic axis and suppressing inflammation
Chang, H., Li, Y., Wang, Z., Fang, Z., Chen, H., Xu, C., Jiao, X., & Gan, Y. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116440 · Cited by 4
The role of CD8+ T cells in the immunoregulation of osteoporosis
Chen, Z., Hu, H., Hu, D., Du, Q., Yang, H. U. I., Xu, R., Yu, P., Hu, X., & Hu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1874242 · Cited by 4
Siglec-15 as a potential molecule involved in osteoclast differentiation and bone metabolism
Lu, J., Zhang, Y., Wen, H., Li, J., Chen, C., & Xiao, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38537 · Cited by 4
Anti-TNFα therapy and prevention of bone loss in rheumatoid arthritis
Roux, C. (2011) · IBMS BoneKEy · doi:10.1138/20110501 · Cited by 4
Effects of Caffeine on Bones of Osteoporotic Rats
Macedo, R. M., Brentegani, L. G., & de Lacerda, S. A. (2012) · Journal of Caffeine Research · doi:10.1089/jcr.2012.0027 · Cited by 4
The Effects of Exercise Intensity Difference on Bone Metabolic Markers and Cytokines of the RANKL/RANK/OPG System in Korean Osteopenia Elderly Women
Kim, C.-S., Kim, H., Kim, J.-Y., Kim, J., Park, D., Lim, S.-T., & Min, S. (2017) · Exercise Science · doi:10.15857/ksep.2017.26.1.87 · Cited by 4
MicroRNAs as Next Generation Therapeutics in Osteoporosis
Kaur, T., Kapila, R., & Kapila, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91223 · Cited by 4
Purification and Biological Function of Caldecrin
Tomomura, A., Bandow, K., & Tomomura, M. (2021) · Medicines · doi:10.3390/medicines8080041 · Cited by 4
Human Papillomavirus Infections and Increased Risk of Incident Osteoporosis: A Nationwide Population-Based Cohort Study
Sheng‐Kai, K., Chin, N.-C., Tu, T.-Y., Wu, Y., Yip, H., Wei, J. C., & Chang, R. (2023) · Viruses · doi:10.3390/v15041021 · Cited by 4
The Role of the Immune System in the Development of Osteoporosis
Mödder, U. I., Riggs, B. L., & Khosla, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10009-3 · Cited by 4
Sex Hormone Signaling in the Lung in Health and Disease: Airways, Parenchyma, and Pulmonary Vasculature
Frump, A. L., & Lahm, T. (2015) · Respiratory medicine · doi:10.1007/978-3-319-23998-9_2 · Cited by 4
How Cells Communicate in the Bone Remodelling Process
Martin, T. J., & Sims, N. A. (2010) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2010.25.1.1 · Cited by 4
Microcirculatory consequences of limb ischemia/reperfusion in ovariectomized rats treated with zoledronic acid
Pócs, L., Janovszky, Á., Ocsovszki, I., Kaszaki, J., Piffkò, J., & Szabó, A. (2019) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-019-1117-x · Cited by 4
RANKL (Receptor activator of NFκB ligand)
Blake, S., & JAMES, I. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50041-7 · Cited by 4
The Role of T Lymphocytes in Bone Remodeling
Fuller, J., Samuel, R. E., Abraham, J. J., Gad, D., Padilla, D. M., & Cottrell, J. A. (2023) · Open Journal of Orthopedics · doi:10.4236/ojo.2023.134014 · Cited by 4
Combination of Pilose Antler Extract and Hydroxytyrosol Enhances Bone Mineral Density in Both Animals and Postmenopausal Women
Ma, X., Ma, Y., Ma, X., Zhang, Z., & Li, Y. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70402 · Cited by 3
Brake–Drive Osteo System: Sequential Modulation of the Inflammatory Microenvironment and Osteogenesis for Osteoporotic Bone Defect Regeneration
Xiao, Z., Feng, C., Xu, C., Zhu, C., Chen, Q., Li, Q., Liu, L., Li, X., Zhu, X., Song, Y., et al. (2026) · Advanced Materials · doi:10.1002/adma.72909 · Cited by 3
Monotropein Protects Mesenchymal Stem Cells from Lipopolysaccharide-Induced Impairments and Promotes Fracture Healing in an Ovariectomized Mouse Model
Zhao, S., Guo, L., Cui, W., Zhao, Y., Wang, J., Sun, K., Zhang, H., Sun, Y.-L., Zhao, D., Hu, X., et al. (2023) · Calcified Tissue International · doi:10.1007/s00223-023-01130-y · Cited by 3
Combined Sequential Antiretroviral Therapy–Induced Immune Reconstitution Bone Loss and Estrogen Deficiency Bone Loss Are Cumulative in Mice Models
Dabeer, S., Tripathi, A. K., Weiss, D., Vikulina, T., Ofotokun, I., & Weitzmann, M. N. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae643 · Cited by 3
Self-citation
The Multiple Components of COPD
Fabbri, L. M., Luppi, F., Beghé, B., & Rabe, K. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_1 · Cited by 3
Physiological Regulation of Bone Metabolism and Estrogen Agonism
García‐Pérez, M. Á. (2006) · Springer eBooks · doi:10.1007/3-540-34742-9_7 · Cited by 3
The Effects of Acute Exercise on RANKL/RANK/OPG Pathway and Bone Metabolic Markers in Healthy College Female
Kim, J., Kim, H., Park, D., Shin, Y., Min, S.-K., & Kim, C.-S. (2018) · Exercise Science · doi:10.15857/ksep.2018.27.3.225 · Cited by 3
CHAPTER 41 – Postmenopausal Osteoporosis: How the Hormonal Changes of Menopause Cause Bone Loss
Pacifici, R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50043-4 · Cited by 11
Self-citation
Shared circulation in parabiosis leads to the transfer of bone phenotype from gld to the wild-type mice
Lukić, I. K., Kovačić, N., Katavić, V., Grčević, D., Ivčević, S., & Marušić, A. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.04.010 · Cited by 3
Attenuation of Osteoporosis by n-3 Lipids and Soy Protein
Fernandes, G. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-740-6_31 · Cited by 3
Locating the ligand binding Sites for the G-protein coupled estrogen receptor (GPER) using combined information from docking and sequence conservationPreprint
Vidad, A., Macaspac, S., & Ng, H. L. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/061051 · Cited by 3
Ovariectomy-induced bone loss through inappropriate inflammatory response: an osteoimmunological perspective on postmenopausal osteoporosis
Higuchi, L., Ouchi, N., Negishi, Y., Naruo, M., Kusano, M., Suzuki, S., Okuda, T., & Morita, R. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2506870 · Cited by 2
Causal Associations of the Alterations in Peripheral Blood Immune Cell Characteristics on the Incidence of Osteoporosis: A Bidirectional Mendelian Randomization Study
Yin, Q., Li, K., Chen, R., Li, X., Lo, W. L. A., Yu, Q., Ding, M., Zhang, S., & Wang, C. (2025) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s518164 · Cited by 2
The impact of alpha-lipoic acid treatment on various mediators of inflammatory and immune responses in a murine arthritis model
Aboelenin, M. M., Hefnawy, M., Emran, T. B., Shafey, H. I., & Zoheir, K. M. A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01941-5 · Cited by 2
Up-regulation of Ifi27l2a expression in bone marrow monocytes contributes to glucocorticoid-induced bone loss
Wang, Z., Huang, C., Liu, S., Xiao, P., Lu, Z., Xu, Y., & Tian, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08985-x · Cited by 2
Acetyl tributyl citrate as a new risk factor for osteoporosis: An integrated study from multi-level toxicological assessment and experimental validation
Qin, S., Li, L., Tang, G., Mu, Y., & Deng, Z. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.119738 · Cited by 2
Oxidative stress in bone healing: mechanisms, disease contexts, and therapeutic strategies
Fu, W., Pan, D., Liu, Y., He, Z., & Hu, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-04478-7 · Cited by 2
Inflammaging and immunosenescence-driven remodeling of the immune microenvironment in osteoarthritis: mechanisms, immune regulation and immune reprogramming
Wang, T., Jiang, W., Chen, X., Fu, S., Hu, K., & Zeng, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1892251 · Cited by 2
Chitosan based bionanocomposites in osteoporosis
Niranjan, M. K., Baghel, K., & Azam, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821280-6.00014-3 · Cited by 2
Pan-immune inflammatory value a new diagnostic biomarker in postmenopausal osteoporosis
Başaran, P. Ö., & Tutan, D. (2024) · Journal of Medicine and Palliative Care · doi:10.47582/jompac.1447017 · Cited by 2
Priming of mouse pre-osteoblasts with Interleukin-3 attenuates TNF-α-induced-inhibition of osteoblast differentiation
Piprode, V., Behera, S., Karhade, J., Mhaske, S. T., & Wani, M. R. (2025) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-025-08610-2 · Cited by 2
Probiotics: Emerging functional ingredients for healthy aging and age-related diseases
Tan, P. L., & Kim, S. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818588-9.00002-4 · Cited by 2
Interaction with Estrogen Receptors as Treatment of Arthritis and Osteoporosis
Carlsten, H. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_11 · Cited by 2
Patogénesis de la osteoporosis: papel de los estrógenos
Rincón-Sierra, O., Díaz-Yamal, I. J., & Pérez-Agudelo, L. E. (2007) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.477 · Cited by 2
Skeletal Health in Pediatric Inflammatory Bowel Disease
Sylvester, F. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-73481-1_11 · Cited by 2
Functional Genetic and Genomic Analysis of Modeled Arthritis
Douni, E. K., Armaka, M., Kontoyiannis, D. L., & Kollias, G. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_4 · Cited by 2
Nuclear Receptor Regulation of Osteoclast and Bone Remodeling
Jin, Z., Li, X., & Wan, Y. (2015) · Cited by 2
EFFECT OF ESTROGEN REPLACEMENT THERAPY ON SERUM CYTOKINES (IL-1α, IL-6, TNF-α) IN OVARIECTOMIZED RATS
Rahnama, M., & Tomaszewski, T. (2002) · Cited by 2
Clinical Disorders Associated with Alterations in Bone Resorption
Rubin, J. E., & Nanes, M. S. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_7 · Cited by 2
The Role of Sex Steroids in the Effects of Immune System on Bone
Grčević, D., Kovačić, N., & Lee, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00012-8 · Cited by 2
Is swimming able to maintain bone health and to minimize postmenopausal bone resorption?
Barreto, T. K. D. P., Bizarria, F. S., Coutinho, M. P. G., Silveira, P. V. D. C., da Silva, K. D. C., Esteves, A. C. F., & de Moraes, S. R. A. (2014) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2014.03.005 · Cited by 2
Idiopathic Condylar Resorption
Posnick, J. C. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2698-1.00036-8 · Cited by 2
Osteoporosis: A Multifactorial Disease
Wu, D., Cline-Smith, A., Shashkova, E. V., & Aurora, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97549 · Cited by 2
Employment of selective pharmacologically active natural compounds in treatment and management of osteoporosis
Upmanyu, V., Sapra, L., & Srivastava, R. K. (2022) · Studies in natural products chemistry · doi:10.1016/b978-0-323-91250-1.00005-7 · Cited by 2
Osteoporosis in men: what is similar and what is different?
Laurent, M. R., Gielen, E., ORWOLL, E. S., & Vanderschueren, D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00025-3 · Cited by 2
Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway
Kim, H. J., Seong, H.-S., Choi, Y.-J., Heo, S. C., & Kim, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218396 · Cited by 2
Colony-Stimulating Factors
Hofstetter, W., & Gillespie, M. T. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50154-2 · Cited by 3
Immunobiology and Bone
Pacifici, R., & Weitzmann, M. N. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch128 · Cited by 2
Self-citation
Bone Microenvironment
Jing, Y., & Chen, X. (2022) · Wiley eBooks · doi:10.1002/9783527837823.ch1 · Cited by 2
The Molecular Pharmacology of Osteoporosis
Iqbal, J. Z., Inzerillo, A. M., Moonga, B. S., & Zaidi, M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_28 · Cited by 2
Genome-Wide Association Study of Osteoporosis Risk in Korean Pre-Menopausal Women: The Korean Genome and Epidemiology Study
Kim, S. K., Hong, S., Kim, G., Ban, J. Y., & Kang, S. W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178177 · Cited by 1
Immunomodulatory inhibition of osteoclastogenesis by a marine microalgal ethanol fraction targeting T-cells, antigen presentation, and macrophage fate
Carletti, A., Pes, K., Tarasco, M., Rosa, J. T., Poudel, S., Pereira, H. G., Louro, B., Cancela, M. L., Laizé, V., & Gavaia, P. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1655321 · Cited by 1
Association between triglyceride glucose-body mass index with all-cause and cardiovascular mortality in adults with osteoporosis: a prospective study
Li, Y., Xie, X., Liu, Y., Sun, H., Gong, Z., & Ding, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1649964 · Cited by 1
Osteoporosis and Fracture Risk in Ovarian Cancer: Beyond the Oncologic Burden
Mineo, M., Arnaldi, G., & Guarnotta, V. (2025) · Diagnostics · doi:10.3390/diagnostics15232966 · Cited by 1
RANKL-convergent osteoimmune network framework in osteoporosis: integrating macrophage activation, T-cell imbalance, and cytokine crosstalk
Zheng, K., Ouyang, Y., Jiang, W., Wang, S., Lan, B., Ramli, N. N. N., & Yin, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1911132 · Cited by 1
Clinically Indicated Corticosteroids Do Not Affect Bone Turnover During Immune Restoration of Severely Lymphopenic HIV-Infected Patients
Grant, P., Sheikh, V., DerSimonian, R., Rupert, A. W., Roby, G. A., Pau, A. K., Sneller, M. C., Rico, S.-V., Brown, T. T., & Sereti, I. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0028 · Cited by 1
Does Ferutinin Dose-Dependently Increase Nodule Formation in TNF-Alpha Activated MC3T3-E1 Preosteoblast-like Cells?
Muravyeva, Y. (2011) · Cited by 1
A natação é capaz de manter a saúde do tecido ósseo e minimizar a reabsorção óssea pós-menopausa?
Barreto, T. K. D. P., Bizarria, F. S., Coutinho, M. P. G., Silveira, P. V. D. C., da Silva, K. D. C., Esteves, A. C. F., & de Moraes, S. R. A. (2014) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2014.03.005 · Cited by 1
Antiinflammatory Properties of Blueberry Using Inflammatory Induced MC3T3-E1 Preosteoblasts
Zhang, J. (2011) · Cited by 1
Role of Prostaglandin E in Receptor Activator of Nuclear Factor-.KAPPA.B Ligand (RANKL) Expression in Osteoblasts Induced by Cell Adhesion to Bone Marrow B-lymphocytes
Hirata, M., Harada, S., Matsumoto, C., Takita, M., Miyaura, C., & Inada, M. (2009) · Eisei kagaku · doi:10.1248/jhs.55.832 · Cited by 1
Bone Healing and Osteoporosis
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_20 · Cited by 2

Authors: Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R.
Affiliations: Barnes-Jewish Hospital (US)
Corresponding author: Pacifici, Roberto
ORCID: Cenci, Simone
Weitzmann, M. Neale
Roggia, Cristiana
Namba, Noriyuki
Novack, Deborah
Pacifici, Roberto
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2000-11-15
Volume: 106
Issue: 10
Pages: 1229-1237
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci11066
PMC: PMC381439
OpenAlex: W2133281510
Cited by: 705
References: 57
Citations by year: 2026: 30 · 2025: 30 · 2024: 14 · 2023: 25 · 2022: 23 · 2021: 27 · 2020: 35 · 2019: 25 · 2018: 19 · 2017: 34 · 2016: 33 · 2015: 37 · 2014: 32 · 2013: 32 · 2012: 28
FWCI: 7.12
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Arthritis Foundation
Eli Lilly and Company
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR041412, AR41412, AR-13534)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords: estrogen deficiency, bone loss, ovariectomy, T cells, TNF-α, osteoclastogenesis, RANKL, macrophage colony-stimulating factor, TNF receptor p55, postmenopausal osteoporosis, bone resorption, nude mice, estrogen receptor, mesenchymal stem cells, T cell deficiency
MeSH terms: Animals, Bone Resorption, Carrier Proteins, Cells, Cultured, Estrogens, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Nude, Osteoclasts, Ovariectomy, T-Lymphocytes, Tumor Necrosis Factor-alpha, Antigens, CD, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-α

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks